Core Points - Venus Concept Inc. has announced a registered direct offering of 434,720 shares of common stock at a price of $2.65 per share, with expected gross proceeds of approximately $1.15 million [1][3] - The company will also issue unregistered short-term warrants to purchase up to 869,440 shares at the same exercise price, potentially generating an additional $2.3 million if fully exercised [1][3] - The offering is expected to close around June 9, 2025, pending customary closing conditions [1] Offering Details - H.C. Wainwright & Co. is acting as the exclusive placement agent for the offering [2] - The shares are being offered under a "shelf" registration statement effective since November 1, 2024, and a final prospectus supplement will be filed with the SEC [4] - The unregistered short-term warrants are offered in a private placement and have not been registered under the Securities Act [5] Company Overview - Venus Concept is a global leader in medical aesthetic technology, offering a range of minimally invasive and non-invasive products across over 60 countries [7] - The product portfolio includes various aesthetic device platforms and hair restoration systems, supported by prominent healthcare growth equity investors [7]

Core Viewpoint - Venus Concept Inc. reported a decline in financial performance for the first quarter of 2025, with total revenue decreasing by 22% year-over-year, attributed to challenging market conditions and timing of new system adoptions [5][10]. Financial Results Summary - Total revenue for Q1 2025 was $13.6 million, down from $17.5 million in Q1 2024, reflecting a decrease of $3.8 million or 21.9% [5][6]. - Revenue breakdown showed a 29.3% decrease in international revenue and a 16.5% decrease in U.S. revenue [6]. - Revenue from products—systems decreased by 25%, and lease systems revenue also saw a 25% decline [6][7]. - Gross profit for Q1 2025 was $8.8 million, a decrease of 25% compared to Q1 2024, with a gross margin of 64.2% [7][10]. - Operating expenses decreased by 6% year-over-year to $18.3 million, driven by reductions in general and administrative, selling and marketing, and research and development expenses [8][9]. - The company reported a GAAP net loss of $12.4 million for Q1 2025, compared to a net loss of $9.8 million in Q1 2024 [10][11]. Management Commentary - The CEO emphasized solid execution despite a challenging environment and indicated a focus on managing cash burn and making targeted investments for long-term growth [3][4]. - The company enhanced its balance sheet with a new bridge loan amendment and two equity capital transactions, indicating validation from investors regarding its potential value creation [3][4]. Cash Position and Debt - As of March 31, 2025, the company had cash and cash equivalents of $3.2 million and total debt obligations of approximately $35.5 million, a decrease from $39.7 million at the end of 2024 [11][12]. - The company is currently not providing full-year 2025 financial guidance due to ongoing evaluations of strategic alternatives and potential trade disruptions [12]. Conference Call Details - Management will host a conference call to discuss the quarterly results, providing an opportunity for questions and answers [13].

Core Viewpoint - Venus Concept Inc. reported financial results for Q4 and FY2024, highlighting ongoing industry challenges and a focus on cost management and strategic growth initiatives [3]. Financial Results Summary Fourth Quarter 2024 - Total revenue decreased by 13% year-over-year to $15.8 million, with U.S. revenue down 13% to $10.3 million and international revenue down 13% to $5.5 million [4][6]. - Revenue from Venus Prime/Subscription systems fell by 58.2%, while products-systems revenue increased by 15.4% [4][6]. - Gross profit decreased by 10% to $10.9 million, with a gross margin of 69.1% [7]. - Operating expenses declined by 11% to $17.6 million, driven by reductions in general and administrative, selling and marketing, and research and development expenses [8]. - The operating loss improved to $6.7 million from $7.6 million year-over-year [9]. - Net loss attributable to stockholders was $8.0 million, or $11.23 per share, compared to a net loss of $11.1 million, or $20.14 per share in the prior year [10]. Fiscal Year 2024 - Total revenue for FY2024 decreased by 15% to $64.8 million, with U.S. revenue down 12% to $38.2 million and international revenue down 19% to $26.7 million [12][14]. - The company achieved a significant reduction in outstanding debt from $74.9 million to $39.7 million, a 47% decrease year-over-year [5]. - Operating loss for FY2024 was $27.2 million, compared to $28.3 million in FY2023 [14]. - Net loss attributable to stockholders was $47.0 million, or $71.17 per share, compared to a net loss of $37.1 million, or $68.11 per share in the previous year [14]. Strategic Developments - The company is focused on reducing cash burn through disciplined cost management while making targeted investments for growth [3]. - Management structure changes were announced to enhance responsiveness and decisiveness in strategic planning [3]. - The company expanded its international distributor network, including partnerships in Taiwan, Colombia, and India [5]. Cash Flow and Financial Position - Cash used in operations in 2024 was $11.1 million, down 14% year-over-year [5]. - As of December 31, 2024, cash and cash equivalents were $4.3 million, down from $5.4 million a year earlier [11]. - The company amended its Bridge Loan Agreement with Madryn to create an additional $10.0 million financing capacity [5].